L-Dex® Analysis for Lymphedema - Medical / Health Care - Medical Equipment
Offer your patients peace of mind. Know their L-Dex score with the leading technology for point-of-care lymphedema assessment.
-
Most popular related searches
Designed for Lymphedema
Designed for Lymphedema
- The L-Dex score, only available from ImpediMed, is designed to detect small lymphedema-related fluid changes in the limbs.
- L-Dex compares the fluid in a limb at-risk for lymphedema to a healthy limb in order to help detect lymphedema.
- L-Dex is FDA-cleared for: unilateral lymphedema and bilateral lymphedema, arms and legs, and women and men.
Accurate Detection
- L-Dex is validated to detect lymphedema at its earliest, subclinical stage
- Detects fluid changes as small as 36 ml (2.4 tablespoons)
- Validated against lymphoscintigraphy
- 80% Sensitive and 90% Specific in detecting subclinical lymphedema following cancer surgery with a 6.5 change from a pre-treatment baseline
Demonstrated Outcomes
- 81% lower incidence of chronic cancer-related lymphedema with BIS L-Dex monitoring and intervention than with circumference monitoring in a meta-analysis of 67,000 patients
- Statistically lower rates of chronic lymphedema in high-risk patients and short-term and long-term follow-up
- Consistent reduction in lymphedema progression, study after study
Extensive Experience
- 16 of the 31 members of the National Comprehensive Cancer Network® (NCCN®) use SOZO with L-Dex
- BIS is recommended in lymphedema clinical practice guidelines from the American Physical Therapy Association, eviCore Healthcare, and the National Lymphedema Network
- Major institutions including University of Kansas, University of Pittsburgh Medical Center, Memorial Sloan Kettering, and MD Anderson have published their experience using L-Dex